Sammanfattning
| Originalspråk | Engelska |
|---|---|
| Artikelnummer | 38 |
| Tidskrift | Nature Communications |
| Volym | 17 |
| Nummer | 1 |
| DOI | |
| Status | Publicerad - dec. 2026 |
| MoE-publikationstyp | A1 Tidskriftsartikel-refererad |
Finansiering
This study was supported by the “Inflammation in human early life: targeting impacts on life-course health” (INITIALISE) consortium funded by the Horizon Europe Program of the European Union under Grant Agreement 101094099 (to M.O.), the Research Council of Finland funding (no. 363417 to S.L.; grants no. 331793 and 329277 to R.L.), the Research Council of Finland project grant (grant no. 333981 to M.O.), and the Novo Nordisk Foundation (grant no. NNF20OC0063971 to T.H. and M.O. and grant no. NNF19OC0057218 to R.L). Further support was received from the Swedish Research Council (grant no. 2016-05176 to T.H. and M.O.), the Sigrid Jusélius Foundation, the Jane and Aatos Erkko Foundation (to R.L.), Formas (grant no. 2019-00869 to T.H. and M.O.), and the Medical Research Funds, Helsinki University Hospital (to M.K.). Further support was received by the InFLAMES Flagship Programme of the Academy of Finland (grant no. 337530). We further acknowledge support by NICHD, P50HD106463, and NIDDK R01DK136117, U24DK133658 (to P.C.D.). RJX is funded by NIH (DK 43351, AI172147) and the Center for Microbiome Informatics and Therapeutics. Mass spectrometric analysis was performed at the Turku Metabolomics Centre with the support of Biocenter Finland. The DIABIMMUNE study was supported by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 202063 (to M.K. and R.L.), Breakthrough T1D (formerly Juvenile Diabetes Research Foundation) grants 17-2011-529 and 17-2014-305 to R.L., and the Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research grant Decision number 250114, 2012–2017 (to M.O., R.L., and M.K.). We thank all voluntary blood donors and personnel of Turku University Hospital, Department of Obstetrics and Gynecology, Maternity Ward (Hospital District of Southwest Finland) for the umbilical cord blood collection. We acknowledge Marjo Hakkarainen (Turku Bioscience Center, University of Turku) and Sarita Heinonen for her excellent technical assistance. We thank Denys Mavrynsky and Tuomas Karskela for the synthesis of pure UDCA conjugates. We also acknowledge Mauricio Caraballo (Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego) and Nicole Avalon (Scripps Institution of Oceanography) for their assistance with the experimental setup for metabolomics and compound purification. Open access funding provided by Örebro University.
Nyckelord
- Metabolomics
- Type 1 diabetes
Fingeravtryck
Fördjupa i forskningsämnen för ”Microbiome-derived bile acid signatures in early life and their association with islet autoimmunity”. Tillsammans bildar de ett unikt fingeravtryck.Citera det här
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver